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Abstract Metastasis of human cancer is an organ-selective
process that is determined by anatomical and biological factors
as well as by specific microenvironmental properties. Dissemi-
nation of visceral malignancies to the skin is rather rare and
usually occurs in a later stage of the disease. Using statistical
approaches, both positive (renal and lung cancers) and negative
(pancreatic and liver cancers) organ preferences can be identi-
fied in a variety of cancers. While certain cancer types are
characterized by random distribution for skin metastasis (liver
cancer), a number of cancers demonstrate a colonization
preference to the region of origin: lung cancer to the
supradiaphragmatic (mostly chest) and colorectal cancers to
the infradiaphragmatic (abdominal) skin regions. In certain
cases, however, skin metastasis develops more frequently at
specific distant locations, as evidenced by the dissemination of
renal cancer at the head and neck region. These findings are
clinically relevant and useful especially in patients where skin
metastasis is the first indication of a malignancy. Nevertheless, it
is a strong argument for the predominant role of microenviron-
mental factors in cancer dissemination. On the other hand, skin
metastases of visceral cancers provide a unique model to ana-
lyze the pathomechanisms determining organ selectivity, includ-
ing the organ-specific vascularization, the dermatome-specific
innervation, or immunological and developmental factors.
Keywords Skin metastasis . Visceral organs . Regional
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1 Introduction
Malignant progression of tumors is characterized by local
invasion, lymphatic spreading to regional lymph nodes, and/or
systemic hematogenous dissemination to distant tissues and
organs described as the metastatic cascade [1]. In most cases,
the survival of patients after successful eradication of the
primary cancer depends on the development of distant metas-
tasis through hematogenous dissemination. While local inva-
sion and locoregional lymphatic spreading are biologically and
pathologically predictable, the hematogenous dissemination is
a rather stochastic process. There are two major
pathomechanisms hypothesized that determine the target organ
of hematogenous metastasis: Paget’s “seed and soil hypothe-
sis” [2] and Ewing’s mechanical/anatomical theory [3]. Tumor
cells can leave the primary tumor site through the venous
drainage of the organ and this would predict that the first
metastatic foci would develop in the filtering organ. This
anatomical constrain could explain the frequent liver metasta-
sis of the colorectal cancer and the lung metastasis of anal and
lower rectal/anal cancers. Both preclinical and clinical studies
demonstrated that circulating cancer cells can be detected at
high frequency in the draining veins of a given primary cancer
[4, 5]. Nevertheless, distant metastasis is a highly inefficient
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(estimated at a rate of 0.01 %) and—importantly—highly
selective process [6, 7]. Typical examples of high selectivity
are bone and brain metastases of breast cancer, visceral metas-
tases ofmalignant melanoma, or suprarenal glandmetastasis of
lung cancer. The metastatic colonization potential of a cancer
depends on the genotype and phenotype of the cancer cells
that determines its capacity to adapt to and/or manipulate the
host organ microenvironment to support its survival, prolifer-
ation, vascularization, and ultimately metastasis formation [8].
2 Skin as a rare metastatic site of cancers
Skin is a relatively rare distant metastatic site of malignant
tumors. Studies performed during the past 50 years found that
about 1 to 5 % of all visceral malignancies form skin metastasis
[9]. Nevertheless, the prevalence may increase due to the longer
survival of cancer patients [10–12]. Although skin is usually
involved in a later stage of progression, it is the first sign of
dissemination in a small fraction of cases [13–15]. However,
there are two key factors that warrant special attention in skin
metastasis statistics. First, a significant proportion of skin me-
tastases are derived from cancer types that are closely connected
to the skin such as melanoma, breast, or head and neck cancers
[13–15]. Second, skin metastasis statistics describe natural fre-
quencies and do not normalize the incidence with respect to the
significant differences in the prevalence of the various cancer
types. In order to establish the real organ preference of various
cancers, skin metastasis numbers need to be adjusted with the
relative prevalence of the specific tumor type. Of note, certain
locations are subject to iatrogenic cell spreading such as the
surgical scars in gastrointestinal cancer that can also influence
the actual incidence of skin metastasis [16].
In this review, we intend to revisit the skin selectivity of
metastasis of visceral cancer types and analyze their ana-
tomical distribution based on literature data.
3 Relative prevalence of skin metastasis of internal
cancers
The rate of skin metastases of various visceral cancers
reported in previous studies is summarized in Table 1. There
are three studies where the rate of skin metastasis for the
majority of visceral cancers can be extracted [11, 17, 18].
We excluded breast and head and neck region (oral cavity,
nasal sinuses, and larynx) cancers since these tumors have
direct anatomical connection to the skin and previous studies
have shown their high preference to skin metastasis. In order
to establish the relative preference of the visceral cancer types
to form skin metastasis, in each series, it is possible to calcu-
late the primary tumor-specific rate of cutaneous metastasis in
relation to the overall rate of skin metastasis in a given cohort.
Another possibility for normalization is to use the specific
incidence or mortality data for the given country and time
period [19–21]. Due to the composition of the individual
patient population in a given institution, this approach pro-
vides less consistent findings (Supplemental Table 1). There-
fore, we averaged these relative rates over the three different
cohorts. Using this approach, we identified two cancer types,
namely, renal and lung cancers, with a high positive prefer-
ence for the skin, while we found pancreatic and liver cancers
with a high negative preference (Fig. 1). These data also
indicate that colorectal, gastric, and genitourinary cancers
are characterized by average skin metastatic preferences.
4 Anatomical distribution of skin metastases of visceral
cancers
The role of local anatomical factors in the formation of skin
metastasis of primary tumors that develop in the vicinity of the
skin or within the skin is plausible. In contrast, in case of skin
metastases of visceral organs, the role of anatomical factors is
more complex. In Table 2, we summarized the various skin
regions as metastatic locations of visceral cancers from previ-
ous studies [13, 18, 22, 23]. Based on these reports, the most
common anatomical locations of skin metastases are the head
and neck, chest, and abdominal regions. There is a rather large
variation in case of the extremities due to the rather varying
ratio of the different primary tumor types.
We performed a meta-analysis on 174 skin metastatic cases
reported in five different studies [15, 18, 22–24] to identify
location preferences of the primary tumors from different
organs (Table 3). Importantly, lung, colorectal, and urogenital
cancers displayed a preference to metastasize to their
Table 1 Rate of cutaneous metastasis of visceral cancers
Overall rate,
% (no. of cases)
Colorectal
(%)
Gastric
(%)
Lung
(%)
Renal
(%)
Pancreas
(%)
Liver
(%)
Genitourinary
(%)
Reference
3.0 (2,247) 4.4 2.0 2.6 4.6 1.9 – 2.6 [11]
0.8 (6,477) 0.8 0.8 1.8 – – 0.3 0.3 [17]
5.4 (1,449) 7.0 4.9 7.6 8.0 1.1 3.8 5.5 [18]
Data are expressed in percent of the number of respective cancer cases
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corresponding supradiaphragmatic and infradiaphragmatic
skin regions. In contrast, skin metastasis of upper gastrointes-
tinal tumors did not retain the original infradiaphragmatic
position of the primary cancer, while skin metastases of renal
cancer switched to the supradiaphragmatic region (Table 3).
To further support the observations above, we compiled
444 skin metastasis cases from 7 previous reports with differ-
ent primary tumors and corresponding regional distribution
data [10, 11, 15, 18, 22–24] and from 2 lung cancer-specific
studies [25, 26]. These data strongly support the notion that
lung cancer preferentially produces chest (and less frequently
head and neck) skin metastases, while colorectal cancer pre-
fers abdominal skin locations in more than two thirds of the
cases (Fig. 2). Although the cohort is more limited for kidney
cancer, a preference to head and neck region skin metastases
was evident. Interestingly, liver cancer showed a random
distribution pattern of skin metastasis (Fig. 2).
5 Pathomechanisms underlying skin metastasis location
preference
5.1 Vascular anatomy and lymphovascular dissemination
There are three major types of skin metastases, namely,
locoregional, in-transit, and distant ones. Melanoma and pri-
mary tumors in proximity to the skin (e.g., breast or head and
neck cancer) preferentially produce skin metastases by
locoregional spreading using mostly the lymphatic dissemina-
tion route [10, 11, 13–15]. In contrast, the mechanism for skin
metastasis tumors residing in the body cavities is far less
understood. With regards to the region-specific blood supply
of the skin, head and neck skin regions are supplied by
branches of external carotid and subclavian arteries, respec-
tively, the skin of the trunk is supplied by spinal arteries, while
the skin of the extremities are supplied from branches of their
arteries derived from the lower aorta. However, this arterial
blood supply heterogeneity does not explain regional varia-
tions in skin metastases either. There is no data indicating a
direct connection of visceral organs and skin through lym-
phatic or blood vasculature. The one exception is the
periumbilical skin region which is directly connected to ab-
dominal organs through the umbilical artery. Accordingly,
abdominal cancers at the stage of peritoneal dissemination
may metastasize into the umbilicus also called Sister Mary
Joseph’s nodule [27]. The primary tumor most frequently is
ovarian carcinoma in women and gastric cancer in men [28].
Despite the direct blood vessel connection, such type of
metastasis is rare among skin metastases [27, 28]. Further-
more, in our recent report on abdominal skin metastases of
gastrointestinal cancers, we found no association with perito-
neal involvement [18]. Similarly, skin metastases of lung
cancers are not associated with pleural involvement either
suggesting that peritoneal or pleural spreading does not facil-
itate visceral cancer metastasis to the skin [18].
There are only two studies analyzing the lymphovascular
invasion of skin metastases that could provide insight into the
pathomechanism. A previous report found a 60–75 %
lymphovascular invasion rate in skin metastases [22]. Howev-
er, the cohort contained predominantly melanoma, breast, and
hematopoietic cancer cases that are known to prefer lymphatic
dissemination. In a study containing exclusively visceral can-
cers, the lymphovascular invasion rate was much lower
(28.6 %) and the majority of tumors contained lymphatic
invasions [18]. Accordingly, locoregional spreading through
lymphatics and the involvement of the corresponding
peritoneal or pleural cavities do not represent the major
pathomechanism of skin metastasis of visceral cancers.
5.2 Blood perfusion rate
The skin is one of the largest organs of the body, but its
share from the cardiac output of blood is rather low: around
5 % under resting conditions [29]. Preclinical studies indi-
cated that intracardiac injection of melanoma cells into mice
followed the distribution of blood in tissues and the rate of
skin metastasis was 5 % [30]. In sharp contrast, in humans, the
incidence of skin metastasis is rather low (<5 % in our series)
and lower than expected from blood flow share, indicating a
general negative preference for this organ by various cancers
Fig. 1 Relative preference for skin metastases in various visceral
cancers from three studies [11, 17, 18]. Primary tumor-specific relative
rate was calculated according to the corresponding average rate from
the study. If the number is >1, it describes a positive preference for skin
metastasis formation
Table 2 Distribution of cutaneous metastasis in skin regions
Region n=80
[18] (%)
n=71
[13] (%)
n=57
[23] (%)
n=78
[22] (%)
Head and neck 21 42 37 25
Chest 25 21 14 8
Abdomen 44 30 25 26
Extremities 5 6 25 31
The total number of cutaneous metastasis and the reference to the study
are given in the column head. Data are expressed as percent of total
cutaneous metastases in the given study
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[18]. There are three major factors that need to be considered
to evaluate the skin as a host during metastasis formation. The
skin, and the dermis in particular, is a very active part of both
the antigen-specific and innate immune system that can inter-
fere with the metastatic process. On the other hand, the skin is
one of the most capillarized tissues in humans with a density
of 70–90 capillaries per mm2 [31, 32]. Considering the spatial
limits of oxygen and nutrient diffusion (around 100 μm),
disseminated cancer cells in the skin do not depend on their
own angiogenic potential. In conclusion, the relatively low
perfusion rate and the active immunity seem to be obstacles
for metastatic dissemination despite the abundance of nutri-
tion and oxygen in the skin.
5.3 Circulating cancer cells
Circulating tumor cells (CTC) can readily be detected in
almost all human malignant diseases and carry the potential
to become metastatic cells [33–35]. Importantly, they can be
detected with a relatively high incidence even in early stage
disease [34]. Reports on the comparison of early and late stage
disease CTC numbers found limited correlation [36, 37]. With
advances of cell isolation technologies, the detection threshold
has become lower, reaching 1–5 CTC/10 ml blood [32]. It is a
well-established fact that the metastatic efficiency of hema-
togenous dissemination is 0.01%; in other words, 1 cell out of
10,000 tumor cells in the circulation [6, 7], indicating that the
overwhelming majority of CTC is incapable of colonizing the
distant organs. Upon further consideration of this fact in the
era of CTC isolation technologies, one can state that CTC
positivity (5/10 ml) means 2,500 CTC in the whole blood
volume in a given moment in a cancer patient. Regarding the
1/104 efficacy rate of cancer cells to metastasize, this low
number of CTC is not necessarily enough for producing a
single metastatic colony. However, this calculation must be
corrected with the share of blood flow of the individual
metastatic organ. In case of the skin, the 5 % means 1/20 of
the entire blood volume, meaning that 20 times more CTC is
necessary to produce 1 single skin colony (equivalent of 250–
500 CTC/10 ml), a very high number that is rarely detected in
humans [33–35]. Due to the aforementioned obstacles in the
skin microenvironment and the low perfusion rate, the colo-
nization of the skin requires a rather high CTC number that
occurs only in a limited number of cancer cases and in general
at late stages.
5.4 Mechanisms of organ selectivity
Statistical analysis of our and two other datasets indicated
that pancreatic and liver cancers show the highest negative
preference and that renal and lung cancers show the
strongest positive preference to skin metastasis (Fig. 1).
In case of the abdominal skin metastasis of colorectal
cancer, the direct umbilical vascular connection may con-
tribute to the preference; however, this type of metastasis is
rather infrequent.
Endothelial cells in capillary beds express unique organ-
specific markers that have previously been identified by
Table 3 Distribution of skin
metastases in relation to the dia-
phragm (meta-analysis)
Skin metastasis (n=174) Diaphragm Number Percent p (χ2)
Colorectal cancer (n=48) Supra 16 33.3 <0.001
Infra 32 66.6
Upper gastrointestinal cancers (n=25) Supra 12 48.0 0.365
Infra 13 52.0
Lung cancer (n=45) Supra 39 86.7 <0.0002
Infra 6 13.3
Renal cancer (n=31) Supra 26 83.9 <0.0002
Infra 5 16.1
Other urogenital cancers (n=25) Supra 5 20.0 <0.0001
Infra 20 80.0
Fig. 2 Regional distribution of skin metastases of visceral cancers
(n=444). The meta-analysis is based on reports as indicated. The statistical
significance of difference from a random distributionwas determined byχ2
test. HN head and neck, CH chest, AB abdominal, EX extremity
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antibody-based [38], lectin-binding [39], phage display
[40], or proteomic technologies [41]. Furthermore, a skin-
specific marker with a defined peptide sequence
(CVALCREACGEGC) has been identified that functions
as a selective adhesion partner for circulating cancer cells
for extravasation [42]. On the other hand, skin-homing
cancer cells must recognize dermal tissues in a highly spe-
cific way. Studies on human melanomas revealed that these
epidermotropic cancer cells express CCR10 chemokine re-
ceptor which is used for skin homing [43]. The ligand for
CCR10 is a skin-specific keratinocyte chemokine, CCL27
[44]. In the dermis, fibroblasts and endothelial cells secrete
SDF1/CXCL12 and its receptor, CXCR4, is present on skin-
homing Sezary lymphoma cells [45]. There has been an
exploratory analysis on three breast and three lung cancer
cases: CCR10 and CXCR4 expressions were determined in
primary tumors with and without skin metastases [17].
CXCR4 was readily expressed in both primary and skin
metastatic tumors of both breast and lung cancer. CCR10
was variably present in both breast and lung primary tumors
but was only present in skin metastases of breast cancers but
not of lung cancer [17]. Since only the minority of skin
metastases of visceral organ cancers is epidermotropic [13],
CCR10 expression might not be crucial for skin-homing for
most cancer types unlike CXCR4. Furthermore, a recent
study found that CXCR4/CXCL12 plays a significant role
in pancreatic cancer organ-specific metastasis [46]. How-
ever, in renal cancer, the incidence of CXCR4 expression
is lower [47, 48] than in colorectal [49, 50] or pancreatic
cancers [51, 52], suggesting that this chemokine system may
not be the primary driver of the skin-selective homing
mechanism.
5.5 Mechanisms underlying regional distribution
Blood circulation-dependent tumor spreading would in-
dicate a randomly distributed skin metastasis pattern,
but there is evidence that most visceral tumors have
preferred skin regions for metastasis. Random skin me-
tastasis pattern characterizes liver cancer dissemination,
but this is an exception. Most skin metastases develop
in a nonrandom manner. Several previous reports [10,
11, 13–15, 18] indicated that significantly more skin
metastases occur in the ventral skin. Furthermore, we
provided new statistical evidence that some visceral
cancer types gave metastases to the skin regions of
the “same level,” such as lung cancer mainly to
supradiaphragmatic (primarily chest), colorectal cancer
mainly to infradiaphragmatic (primarily abdominal),
and genitourinary cancers to lower abdominal sites, as
suggested by earlier observations [10, 11, 13–15]. It is
also of note that skin metastases do not respect the
laterality of the primary tumor [18]. On the other hand,
in case of certain visceral cancers, we have found a
peculiar nonregional skin preference, e.g., the head and
neck localization of kidney cancer metastases. These
observations are strong arguments for the existence of
certain “homing” mechanisms that determine the termi-
nal point of CTC in the skin tissue.
Although being a unified organ, the skin of the body is
characterized by regional anatomical/histological differ-
ences in respect to hair density, epidermal characteristics,
thickness of the dermis, and amount of underlying adipose
tissue. It is another heterogeneity factor that skin regions can
be divided into 30 dermatomes based on the spinal nerve
innervation [53]. While these dermatomes are highly uni-
form in the thoracic and abdominal regions, they are very
complex on the extremities. It is intriguing that certain
cancers (such as lung or colon cancer) follow their derma-
tomal segments in skin metastasis (T1–T7 and T8–L1, re-
spectively), while others such as renal cancers prefer the
cervical dermatomes. Perineural invasion of various cancer
types (breast, colorectal, pancreatic, gastric, prostate, or
head and neck cancers) is a common feature in the primary
tumors with prognostic significance. Meanwhile in our co-
hort, we did not find perineural invasion in skin metastases
[18] and earlier pathological analyses have not mentioned
them either [10, 11, 13–15], making a peripheral nerve
association of skin metastasis development highly un-
likely. Skin is also patterned by a developmental seg-
mentation called Blaschko lines that do not follow
nerves, blood vessels, or lymphatics, though they are
similar to dermatomes [54]. Certain skin diseases clearly
follow such embryonal patterns as lichen or nevoid
disorders [54]. Since the molecular biological basis of these
skin patterns is not known yet, it is impossible to speculate
further concerning the “seed and soil” hypothesis of skin
metastasis formation.
6 Conclusion
Skin metastasis of visceral cancers is another strong proof
for the validity of the seed and soil hypothesis, i.e., the
organ-selective nature of the metastasis formation process.
The molecular basis of this selective process is largely
unknown, although in case of certain organs such as the
lung or the bone, basic mechanisms are defined. In general,
it can be concluded that skin metastasis is a rare form of
cancer dissemination due to the unique physiology of this
organ. On the other hand, if it occurs, it is frequently a
nonrandom process which can be used for the identification
of the primary tumor in the event this is the first sign of the
disease. Among the various cancer types, there are several
which exhibit positive or negative preferences for skin col-
onization even in an advanced late stage. Identification of
Cancer Metastasis Rev (2013) 32:493–499 497
the underlying molecular mechanisms behind this process
can also contribute to better understanding of the cancer
dissemination process in general.
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